LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q1)Aug 30, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -38.99%2.38M | -82.46%1.76M | -79.14%1.22M | -151.47%-2.82M | -179.49%-545K | -28.57%3.9M | 563.86%10.01M | 865.06%5.87M | 61.75%-1.12M | -105.84%-195K |
Net income from continuing operations | -85.88%660K | 127.77%33.16M | 290.51%23.86M | -135.60%-1.47M | 63.46%6.09M | 693.55%4.67M | 54.04%14.56M | 5.47%6.11M | 84.22%4.13M | 419.53%3.73M |
Depreciation and amortization | 82.58%566K | 24.02%1.36M | 31.45%372K | 57.87%371K | -35.01%310K | 198.08%310K | 5.17%1.1M | -63.86%283K | 107.96%235K | 527.63%477K |
Deferred tax | --144K | ---20.77M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Change In working capital | 109.49%140K | -83.37%-14.38M | -231.83%-3.01M | 60.49%-2.31M | -52.46%-7.58M | -138.01%-1.48M | 23.84%-7.84M | 88.93%-908K | 4.81%-5.84M | -372.34%-4.97M |
-Change in receivables | -25.66%2.56M | 279.25%6.79M | 16.57%-4.34M | 24.67%-907K | 270.97%8.6M | -55.06%3.44M | 51.65%-3.79M | -18.77%-5.2M | -2.91%-1.2M | -58.23%-5.03M |
-Change in inventory | 62.62%-2.88M | -45.02%-13.73M | 116.75%450K | -13.47%-4.19M | -197.28%-2.29M | -231.64%-7.7M | -41.88%-9.47M | -119.27%-2.69M | -198.22%-3.69M | 73.30%-771K |
-Change in prepaid assets | -898.89%-719K | -3,225.00%-875K | -241.03%-275K | 5,572.41%1.65M | -16,778.57%-2.34M | 142.86%90K | 139.44%28K | 553.49%195K | -9.38%29K | -90.07%14K |
-Change in payables and accrued expense | 40.07%-338K | -183.67%-4.67M | -91.41%419K | -50.26%973K | -950.93%-5.5M | 70.27%-564K | 97.45%5.58M | 145.10%4.88M | 831.43%1.96M | -30.01%646K |
-Change in other current liabilities | -632.14%-205K | 24.60%-423K | -80.43%-166K | -112.66%-168K | 69.19%-61K | 85.42%-28K | 23.98%-561K | ---92K | ---79K | ---198K |
-Change in other working capital | -47.57%1.73M | -498.10%-1.47M | -55.09%899K | 111.74%335K | -1,738.52%-6M | 285.26%3.29M | -83.20%369K | 152.64%2M | 28.13%-2.85M | -94.64%366K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -38.99%2.38M | -82.46%1.76M | -79.14%1.22M | -151.47%-2.82M | -179.49%-545K | -28.57%3.9M | 563.86%10.01M | 865.06%5.87M | 61.75%-1.12M | -105.84%-195K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -161.03%-10.81M | 192.47%17.25M | -100.67%-46K | 96.59%-263K | 99.12%-156K | 21,190.48%17.72M | -4,384.62%-18.66M | 3,542.42%6.82M | -8,877.91%-7.72M | -24,101.37%-17.67M |
Net PPE purchase and sale | 30.63%-197K | 45.01%-749K | 96.11%-46K | -232.91%-263K | -940.00%-156K | -238.10%-284K | -227.40%-1.36M | -497.98%-1.18M | 8.14%-79K | 79.45%-15K |
Net business purchase and sale | ---10.62M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | --0 | 204.08%18M | --0 | --0 | --0 | --18M | ---17.29M | --8M | ---7.64M | ---17.65M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -161.03%-10.81M | 192.47%17.25M | -100.67%-46K | 96.59%-263K | 99.12%-156K | 21,190.48%17.72M | -4,384.62%-18.66M | 3,542.42%6.82M | -8,877.91%-7.72M | -24,101.37%-17.67M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 84.73%-106K | -98.10%139K | 128.80%421K | -97.82%158K | -59.03%254K | 4.14%-694K | -71.58%7.32M | -49.03%184K | 27,753.85%7.24M | -97.54%620K |
Net issuance payments of debt | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net common stock issuance | 83.99%-162K | -101.06%-72K | -10.14%1.48M | ---- | ---- | 14.16%-1.01M | -71.62%6.82M | 346.34%1.65M | ---- | ---- |
Proceeds from stock option exercised by employees | -82.39%56K | -29.47%1.81M | -10.05%537K | -79.13%178K | 17.81%774K | -30.11%318K | -28.03%2.56M | 41.81%597K | --853K | --657K |
Net other financing activities | ---- | 22.52%-1.6M | ---- | ---- | ---- | ---- | -380.19%-2.06M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 84.73%-106K | -98.10%139K | 128.80%421K | -97.82%158K | -59.03%254K | 4.14%-694K | -71.58%7.32M | -49.03%184K | 27,753.85%7.24M | -97.54%620K |
Net cash flow | ||||||||||
Beginning cash position | 63.25%49.31M | -4.31%30.2M | 175.30%47.73M | 167.30%50.66M | 41.07%51.11M | -4.31%30.2M | 577.05%31.56M | -45.99%17.34M | -46.02%18.95M | 448.06%36.23M |
Current changes in cash | -140.81%-8.54M | 1,547.17%19.15M | -87.57%1.6M | -82.83%-2.93M | 97.41%-447K | 349.67%20.92M | -104.93%-1.32M | 2,230.46%12.87M | 46.53%-1.6M | -160.49%-17.24M |
Effect of exchange rate changes | 140.91%9K | -10.81%-41K | -950.00%-21K | 71.43%-4K | 119.35%6K | -320.00%-22K | -175.51%-37K | -102.94%-2K | 6.67%-14K | -1,450.00%-31K |
End cash Position | -20.20%40.78M | 63.25%49.31M | 63.25%49.31M | 175.30%47.73M | 167.30%50.66M | 41.07%51.11M | -4.31%30.2M | -4.31%30.2M | -45.99%17.34M | -46.02%18.95M |
Free cash flow | -39.65%2.18M | -88.36%1.01M | -74.85%1.18M | -156.82%-3.09M | -233.81%-701K | -32.73%3.62M | 692.03%8.65M | 585.39%4.68M | 60.23%-1.2M | -106.43%-210K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |